Browse by Journal Title

Article

Excessive hypertension and end-organ damage in a transgenic mouse line carrying the rat angiotensinogen gene.
Xu, P., Wang, Y., Sterner-Kock, A., Bader, M., Schultheiss, H.P. and Walther, T.
Journal of Cardiovascular Pharmacology 53 (1): 38-43. January 2009

The endothelium-dependent vasodilator effect of the nonpeptide Ang(1-7) mimic AVE 0991 is abolished in the aorta of Mas-knockout mice.
Lemos, V.S., Silva, D.M., Walther, T., Alenina, N., Bader, M. and Santos, R.A.
Journal of Cardiovascular Pharmacology 46 (3): 274-279. 1 September 2005

Fluorescence resonance energy transfer analysis reveals the existence of endothelin-A and endothelin-B receptor homodimers.
Gregan, B., Schaefer, M., Rosenthal, W. and Oksche, A.
Journal of Cardiovascular Pharmacology 44 (Suppl 1): S30-S33. November 2004

Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation.
Dorr, G., Schmidt, G., Graefe, M., Regitz-Zagrosek, V. and Fleck, E.
Journal of Cardiovascular Pharmacology 39 : 523-532. 1 April 2002

Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
de Boer, R.A., van Geel, P.P., Pinto, Y.M., Suurmeijer, A.J.H., Crijns, H.J.G.M., van Gilst, W.H. and van Veldhuisen, D.J.
Journal of Cardiovascular Pharmacology 39 (4): 610-619. April 2002

Molecular interactions of vasoactive systems in cardiovascular damage.
Bader, M.
Journal of Cardiovascular Pharmacology 38 (2): S7-S9. 1 January 2001

Evidence for downregulation of the endothelin-B-receptor by the use of fluorescent endothelin-1 and a fusion protein consisting of the endothelin-B-receptor and the green fluorescent protein.
Oksche, A., Boese, G., Horstmeyer, A., Papsdorf, G., Furkert, J., Beyermann, M., Bienert, M. and Rosenthal, W.
Journal of Cardiovascular Pharmacology 36 (5 Suppl 1): S44-S47. November 2000

Insulin resistance in chronic heart failure.
Coats, A.J., Anker, S.D. and Anker, S.
Journal of Cardiovascular Pharmacology 35 : S9-14. 1 January 2000

Angiotensin II AT1-receptor blockade inhibits monocyte activation and adherence in transgenic (mRen2)27 rats.
Strawn, W.B., Gallagher, P.E., Tallant, E.A., Ganten, D. and Ferrario, C.M.
Journal of Cardiovascular Pharmacology 33 : 341-351. 1 March 1999

Microalbuminuria as a predictive factor for cardiovascular events.
Luft, F.C. and Agrawal, B.
Journal of Cardiovascular Pharmacology 33 Suppl. 1; discussion S41-S43 : S11-S15. 15 January 1999

Dissociation of the effects of forskolin and dibutyryl cAMP on force of contraction and phospholamban phosphorylation in human heart failure.
Neumann, J., Bartel, S., Eschenhagen, T., Haverich, A., Hirt, S., Karczewski, P., Krause, E.G., Schmitz, W., Scholz, H., Stein, B. and Thoenes, M.
Journal of Cardiovascular Pharmacology 33 : 157-162. 1 January 1999

Interaction of the renin-angiotensin system and the endothelin system in cardiac hypertrophy.
Stula, M., Pinto, Y.M., Gschwend, S., Teisman, A.C., van Gilst, W.H., Bohm, M., Dietz, R. and Paul, M.
Journal of Cardiovascular Pharmacology 31 Suppl. 1 : S403-S405. 1 January 1998

Transcriptional regulation of endothelin-1 by erythropoietin in endothelial cells.
Liefeldt, L., Schmidt-Ott, K.M., Orzechowski, H.D., Distler, A. and Paul, M.
Journal of Cardiovascular Pharmacology 31 (Suppl 1): S464-S466. 1998

Single-cell characterization of endothelin system gene expression in the cerebellum in situ.
Schmidt-Ott, K.M., Tuschick, S., Kirchhoff, F., Verkhratsky, A., Liefeldt, L., Kettenmann, H. and Paul, M.
Journal of Cardiovascular Pharmacology 31 (Suppl 1): S364-S366. 1998

Improvement of vagal tone by ACE inhibition: a mechanism of cardioprotection in patients with mild-to- moderate heart failure.
Osterziel, K.J. and Dietz, R.
Journal of Cardiovascular Pharmacology 27 Suppl. : S25-S30. 1 January 1996

Regulation of the endothelin system in transgenic rats expressing the human endothelin-2 gene.
Liefeldt, L., Boecker, W., Schoenfelder, G., Zintz, M. and Paul, M.
Journal of Cardiovascular Pharmacology 26 (Suppl:3): S32-S33. 1 January 1995

Plasma endothelin-1 levels in human lung transplant recipients.
Shennib, H., Serrick, C., Saleh, D., Reis, A., Stewart, D.J. and Giaid, A.
Journal of Cardiovascular Pharmacology 26 Suppl 3 : S516-S518. 1 January 1995

Cardiac norepinephrine, beta-adrenoceptors, and Gialpha- proteins in prehypertensive and hypertensive spontaneously hypertensive rats.
Boehm, M., Castellano, M., Paul, M. and Erdmann, E.
Journal of Cardiovascular Pharmacology 23 : 980-987. 1 January 1994

The renin-angiotensin system in the heart and vascular wall: New therapeutic aspects.
Falkenhahn, M., Gohlke, P., Paul, M., Stoll, M. and Unger, T.
Journal of Cardiovascular Pharmacology 24 : S6-S13. 1 January 1994

Genetics of primary hypertension.
Ganten, D., Schmidt, S. and Paul, M.
Journal of Cardiovascular Pharmacology 24 : S45-S50. 1 January 1994

Effects of enalaprilat on circadian profiles in blood pressure and heart rate of spontaneously and transgenic hypertensive rats.
Lemmer, B., Witte, K., Makabe, T., Ganten, D. and Mattes, A.
Journal of Cardiovascular Pharmacology 23 : 311-314. 1 January 1994

Converting enzyme inhibition improves congestion and survival in hypertensive rats with high-output heart failure.
Nishimura, H., Oka, T., Ueyama, M., Kubota, J. and Kawamura, K.
Journal of Cardiovascular Pharmacology 23 : 149-154. 1 January 1994

Interactions between the renin-angiotensin system and the parasympathetic nervous system in heart failure.
Osterziel, K.J., Haenlein, D. and Dietz, R.
Journal of Cardiovascular Pharmacology 24 Suppl. 2 : S70-S74. 1 January 1994

The transition from experimental to clinical pharmacology: the renin-angiotensin paradigm.
Ganten, D.
Journal of Cardiovascular Pharmacology 22 (Suppl.1) : S14-S29. 1 January 1993

Torasemide in the treatment of arterial hypertension.
Luft, F.C.
Journal of Cardiovascular Pharmacology 22 Suppl. 3 : S32-S39. 1 January 1993

The brain renin-angiotensin system - localization and general significance.
Bunnemann, B., Fuxe, K. and Ganten, D.
Journal of Cardiovascular Pharmacology 19 (Suppl 6): S51-S62. 1 January 1992

Left ventricular remodeling after myocardial infarction - does the cardiac renin angiotensin system play a role?
Lindpaintner, K., Niedermaier, N., Drexler, H. and Ganten, D.
Journal of Cardiovascular Pharmacology 20 : S41-S47. 1 January 1992

The molecular basis of cardiovascular hypertrophy: the role of the renin angiotensin system.
Paul, M. and Ganten, D.
Journal of Cardiovascular Pharmacology 19 (Suppl 5): S51-S58. 1 January 1992

The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
Thierfelder, L., Holubarsch, C., Hasenfuss, G., Heiss, H.W. and Just, H.
Journal of Cardiovascular Pharmacology 17 : 593-599. 1 April 1991

Improvement of diastolic filling in hypertensive patients treated with cilazapril.
Haberbosch, W., De Simone, R., Dietz, R., Waas, W., Tillmanns, H. and Kuebler, W.
Journal of Cardiovascular Pharmacology 17 (Suppl 2): S159-S162. 1 January 1991

Editorial

The Gross, Franz Hypertension Symposium Series - Introduction.
Ganten, D.
Journal of Cardiovascular Pharmacology 20 : 5-6. 1 January 1992